Evaluation of Plasma MicroRNAs as Diagnostic and Prognostic Biomarkers in Pancreatic Adenocarcinoma: miR-196a and miR-210 Could Be Negative and Positive Prognostic Markers, Respectively

Table 4

Univariate survival analysis of prognostic factors based on miRNA expression.

	MST of lower expression (month)	MST of higher expression (month)	value
miR-21	7.0	7.4	0.714
miR-210	6.6	11.7	0.003
miR-155	7.0	7.1	0.822
miR-196a	12.5	6.3	0.001
miR-20a	11.7	7.0	0.394
miR-25	6.3	10.1	0.362